Profile data is unavailable for this security.
About the company
Brii Biosciences Ltd is a biotechnology company based in China and the United States principally engaged in developing therapies for infectious diseases. The Company’s products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases, which have significant public health burdens. The Company is also developing therapies for COVID-19 and other diseases.
- Revenue in HKD (TTM)668.81k
- Net income in HKD-189.51m
- Incorporated2017
- Employees128.00
- LocationBrii Biosciences Ltd3rd Floor, Building 7Zhongguancun Dongsheng, InternationalNo. 1 North Yongtaizhuang Road, HaidianBEIJING 100192ChinaCHN
- Websitehttps://www.briibio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kintor Pharmaceutical Ltd | 0.00 | -702.48m | 375.90m | 290.00 | -- | 0.2616 | -- | -- | -1.75 | -1.75 | 0.00 | 3.21 | 0.00 | 0.00 | -- | 0.00 | -35.76 | -- | -43.09 | -- | -- | -- | -- | -- | 2.69 | -- | 0.1957 | -- | -100.00 | -- | -13.33 | -- | -- | -- |
Uni-Bio Science Group Ltd | 494.67m | 63.27m | 474.60m | 340.00 | 7.75 | 2.18 | 6.10 | 0.9594 | 0.0099 | 0.0099 | 0.0777 | 0.0353 | 1.72 | 2.63 | 12.38 | 1,336,949.00 | 22.06 | -13.46 | 30.37 | -17.36 | 78.68 | 81.06 | 12.79 | -13.99 | 2.04 | 113.29 | 0.0824 | -- | 24.59 | 22.99 | 296.58 | -- | 1.74 | -- |
Clover Biopharmaceuticals Ltd | 278.58k | -721.05m | 538.23m | 764.00 | -- | 17.35 | -- | 1,932.04 | -0.7099 | -0.7099 | 0.0002 | 0.0239 | 0.00006 | 0.0002 | 0.0126 | 364.64 | -16.04 | -- | -40.13 | -- | 21.40 | -- | -258,830.30 | -- | 0.6913 | -6.95 | 0.9411 | -- | -- | -- | 59.25 | -- | -- | -- |
Tianda Pharmaceuticals Ltd | -100.00bn | -100.00bn | 580.51m | 820.00 | -- | 0.965 | -- | -- | -- | -- | -- | 0.2798 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.10 | -- | 0.1488 | -- | -- | -- | -- | -- | -- | -- |
Genor Biopharma Holdings Ltd | 14.07m | -649.45m | 594.19m | 222.00 | -- | 0.3488 | -- | 42.24 | -1.28 | -1.28 | 0.0277 | 3.35 | 0.0061 | 0.0049 | 0.1629 | 53,279.03 | -28.10 | -- | -31.48 | -- | 98.49 | -- | -4,614.84 | -- | 6.51 | -- | 0.021 | -- | -- | -- | 15.60 | -- | -- | -- |
Pak Fah Yeow International Ltd | 217.41m | 88.16m | 638.86m | 99.00 | 7.25 | 0.8429 | 6.68 | 2.94 | 0.2829 | 0.2829 | 0.6976 | 2.43 | 0.2503 | 2.68 | 20.72 | 2,288,547.00 | 10.15 | 2.39 | 10.81 | 2.52 | 79.03 | 78.86 | 40.55 | 15.05 | 5.03 | -- | 0.0072 | 136.16 | 5.28 | -3.76 | -21.56 | -21.82 | -36.22 | -13.57 |
Brii Biosciences Ltd | 668.81k | -189.51m | 678.56m | 128.00 | -- | 0.2006 | -- | 1,014.58 | -0.2605 | -0.2605 | 0.0009 | 4.64 | 0.0002 | -- | -- | 5,225.10 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
Antengene Corporation Ltd | 72.96m | -629.99m | 681.64m | 201.00 | -- | 0.5481 | -- | 9.34 | -1.02 | -1.02 | 0.1186 | 1.84 | 0.0358 | 0.9773 | 3.41 | 362,969.90 | -30.91 | -53.57 | -36.46 | -58.94 | 81.74 | -- | -863.51 | -1,987.01 | 6.43 | -- | 0.1491 | -- | -57.97 | -- | 3.38 | -- | -- | -- |
Fusen Pharmaceutical Co Ltd | 718.22m | -12.05m | 712.46m | 1.12k | -- | 1.07 | 27.20 | 0.992 | -0.016 | -0.016 | 0.9525 | 0.8893 | 0.5235 | 3.20 | 7.84 | 619,692.50 | -0.8794 | 3.33 | -1.63 | 6.05 | 48.96 | 52.20 | -1.68 | 8.90 | 0.6164 | 1.92 | 0.321 | 14.28 | 27.51 | 1.67 | -307.90 | -- | 26.63 | -- |
Lee's Pharmaceutical Holdings Ltd | 1.10bn | 38.94m | 712.49m | 1.06k | 18.30 | 0.3609 | 7.22 | 0.6499 | 0.0661 | 0.0661 | 1.86 | 3.35 | 0.357 | 1.57 | 8.31 | 994,818.50 | 1.29 | 15.77 | 1.67 | 21.07 | 57.99 | 64.27 | 3.62 | 41.78 | 0.5417 | 5.96 | 0.0963 | 5.25 | -2.61 | 4.10 | -97.42 | -26.09 | -4.38 | -28.09 |
Jbm (Healthcare) Ltd | 610.30m | 97.99m | 717.38m | 258.00 | 7.92 | 0.7646 | 4.82 | 1.18 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
JW (Cayman) Therapeutics Co Ltd | 188.46m | -832.49m | 751.62m | 398.00 | -- | 0.4112 | -- | 3.99 | -2.02 | -2.02 | 0.4579 | 4.43 | 0.0704 | 1.88 | 65.54 | 473,506.60 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.90 | -11.83 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -- | -- |
Sirnaomics Ltd | 0.00 | -660.15m | 784.36m | 180.00 | -- | 1.23 | -- | -- | -8.68 | -8.68 | 0.00 | 7.28 | 0.00 | -- | -- | 0.00 | -55.22 | -- | -57.51 | -- | -- | -- | -- | -- | -- | -- | 0.3655 | -- | -- | -- | 58.56 | -- | -- | -- |
Zhaoke Ophthalmology Ltd | 12.25m | -520.38m | 857.44m | 321.00 | -- | 0.3533 | -- | 69.98 | -0.9582 | -0.9582 | 0.0226 | 4.44 | 0.0044 | -- | 0.4111 | 41,819.99 | -18.76 | -- | -20.18 | -- | 89.83 | -- | -4,246.90 | -- | 6.89 | -86.63 | 0.0807 | -- | -- | -- | 80.88 | -- | -- | -- |
Transcenta Holding Limited | 125.98m | -477.29m | 916.39m | 318.00 | -- | 0.6661 | -- | 7.27 | -1.14 | -1.14 | 0.3006 | 3.15 | 0.0534 | 4.09 | 4.55 | 393,679.50 | -20.21 | -- | -26.51 | -- | 23.17 | -- | -378.87 | -- | 1.56 | -51.37 | 0.2621 | -- | 102.80 | -- | 76.29 | -- | -- | -- |
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 911.63m | 240.86m | 980.44m | 928.00 | 4.07 | -- | 7.97 | 1.08 | 0.4299 | 0.4299 | 1.63 | -- | -- | -- | -- | 1,107,696.00 | -- | 8.64 | -- | 11.48 | 70.15 | 81.71 | 26.42 | 22.22 | -- | 149.92 | -- | 12.20 | 19.30 | 5.45 | 35.09 | 6.04 | -20.57 | -- |
Data as of Mar 28 2024. Currency figures normalised to Brii Biosciences Ltd's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
Invesco Advisers, Inc.as of 10 Feb 2023 | 33.75m | 4.63% |
E Fund Management Co., Ltd.as of 30 Jun 2023 | 22.80m | 3.13% |
UBS Asset Management (Hong Kong) Ltd.as of 31 Jan 2024 | 5.97m | 0.82% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 5.67m | 0.78% |
Xinyuan Asset Management Co., Ltd.as of 30 Jun 2023 | 697.50k | 0.10% |
SSgA Funds Management, Inc.as of 07 Mar 2024 | 276.50k | 0.04% |
American Century Investment Management, Inc.as of 07 Mar 2024 | 111.50k | 0.02% |
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2023 | 62.00k | 0.01% |
Truvalue Asset Management Co. Ltd.as of 30 Jun 2023 | 5.50k | 0.00% |
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2022 | 2.00k | 0.00% |
More ▼
Data from 30 Jun 2023 - 21 Mar 2024Source: FactSet Research Systems Inc.